A method for the rapid detection of cytomegalovirus (CMV) in MRC-5 cells 48 h after inoculation with clinical specimens was developed. A commercially available monoclonal antibody to a CMV early nuclear antigen was used in an indirect immunoperoxidase (IPA) staining procedure performed directly on acetonefixed cell monolayers in standard tubes (16 by 125 mm). Of 190 clinical specimens tested, 30 specimens produced CMV cytopathic effect in tissue culture (TC-CPE) within 14 days after inoculation and, of these 30, 28 were positive for CMV after 48 h by the IPA staining procedure (sensitivity, 93%). Of the remaining 160 clinical specimens negative by TC-CPE within 14 days, 7 were positive by the IPA stain (specificity, 96%). However, three of these seven specimens were positive by TC-CPE upon subculture after the initial 14-day incubation period, and one specimen was overgrown by herpes simplex virus type 2 before CMV cytopathic effect could develop. The mean time to appearance of cytopathic effect for the 30 specimens positive by TC-CPE within 14 days was 6.7 days. These findings indicate that this IPA staining is a useful method for the rapid detection of CMV in cell monolayers inoculated with clinical specimens.
Cytomegalovirus (CMV) infections in humans are usually subclinical, but severe disease may occur in congenital infections, in organ transplant recipients, and in patients with acquired immune deficiency syndrome (AIDS). The diagnosis of CMV infection is difficult to make clinically and usually requires laboratory confirmation. The most sensitive method for the laboratory diagnosis of active CMV infection is virus isolation in tissue culture (16) . However, the mean time to initial observation of CMV cytopathic effect (CPE) is 7 days after inoculation of clinical specimens onto susceptible cell monolayers (6) . A more rapid test for the demonstration of active CMV infection is needed, especially with the increasing availability of antiviral agents for clinical trials. Electron microscopy (9) , cytology (14) , detection of viral antigen by enzyme immunoassay (11) or immunofluorescence (1, 16) , detection of viral nucleic acid by DNA hybridization (2, 15) , and measurement of virus-specific immunoglobulin M (IgM) antibody (7) are some of the methods that have been proposed for the rapid diagnosis of CMV infections. However, these procedures are cumbersome, insensitive, nonspecific, or available only in certain research laboratories.
The detection of CMV early nuclear antigens in tissue culture by anti-complement immunofluorescence has been reported to be diagnostic within 24 h of inoculation of specimens when polyclonal anti-CMV hyperimmune sera are employed (16) . Monoclonal antibodies reactive with CMV early nuclear antigens have been shown to produce nuclear staining by indirect immunofluorescence beginning as early as 2 h postinfection and continuing throughout a 108-h incubation period after inoculation of cell monolayers (5, 8) . A recent study reported that a commercially available monoclonal antibody directed against a CMV early nuclear antigen detected 100% of tissue culture-positive urine spec-* Corresponding author.
imens when either indirect immunofluorescence or peroxidase-antiperoxidase procedures were performed at 36 h postinfection (4). However, this high level of sensitivity was achieved only when specimens were centrifuged onto human diploid fibroblast MRC-5 cells grown on cover slips in 1-dram (4-g) shell vials. The monoclonal antibody detected only 37.5% of tissue culture-positive specimens at 36 h postinfection when the centrifugation step was omitted.
In the present study, we evaluated an indirect immunoperoxidase (IPA) staining procedure at 48 h postinoculation of clinical specimens with the same commercially available monoclonal antibody. The sensitivity and specificity of this technique were compared with those of the development of CPE in MRC-5 cell monolayers within a 14-day incubation period (TC-CPE) (6) . Unlike in the previous study, specimens were simply inoculated onto MRC-5 cell monolayers in culture tubes (16 by 125 mm) without centrifugation, and the IPA staining was performed directly in the tube. In addition, the present study was not limited to urine specimens but included a variety of clinical specimens submitted for CMV isolation. Virus. The AD-169 strain of human CMV, herpes simplex virus type 1 (Maclntyre strain) and type 2 (MS strain), varicella-zoster virus (Ellen strain), and adenovirus type 27 (BP-4 strain) were obtained from the American Type Culture Collection, Rockville, Md.
Virus isolation. Clinical specimens were processed and treated with antibiotics by standard methods (12) and passed through a filter (pore size, 0.45 ,um), and 0.2 ml of the resulting fluid was inoculated onto two MRC-5 cell monolayers. An additional monolayer was inoculated with 0. of unfiltered specimen. After a 48-h incubation period at 36°C, the IPA staining was performed on one monolayer inoculated with a filtered sample. The remaining tissue culture tubes were observed by the TC-CPE method for the development of CMV CPE within a 14-day incubation period as previously described (6). IPA assay. The medium was removed from each tissue culture tube to be stained, the cell monolayer was rinsed with phosphate-buffered saline (PBS) (pH 7.2), and the monolayer was fixed with acetone for 10 min. The acetone was removed from the tube and discarded, and the monolayer was rinsed with PBS.
The optimal working dilutions for the anti-CMV early nuclear antigen monoclonal antibody (Biotech Research Laboratories, Inc., Rockville, Md.) and the peroxidase-conjugated goat anti-mouse IgG antiserum (Cappel Laboratories, Westchester, Pa.) were determined by checkerboard titration on MRC-5 cell monolayers inoculated with the AD-169 strain of human CMV and exhibiting typical CPE in about 50% of the cells. Approximately 0.2 ml of fivefold dilutions of monoclonal anti-CMV antibody in PBS was added to the appropriate tubes and incubated for 30 min at 370C.
The monolayers were rinsed twice with PBS for 10 min, and 0.2 ml of twofold dilutions of the peroxidase conjugate in PBS was added to the corresponding tubes and incubated for 30 min at 37°C. The monolayers were rinsed twice with PBS for 10 minutes, and 2.0 ml of freshly prepared substrate solution (60 mg of 3,3'-diaminobenzidine tetrahydrochloride and 300 [LI of 3% hydrogen peroxide in 100 ml of PBS) was added to each tube for 5 min at room temperature. The substrate solution was removed, and the tubes were rinsed and half-filled with distilled water. The monolayers were then examined at a magnification of x40 for the presence of any darkly stained nuclei.
The sensitivity of the IPA stain at 48 h postinfection was initially compared with that of TC-CPE within a 14-day incubation period by performing each procedure on duplicate monolayers inoculated with serial 10-fold dilutions of a solution containing 104 50% tissue culture infectious doses of the AD-169 strain of human CMV. The specificity of the IPA stain was evaluated by staining MRC-5 cell monolayers infected with reference strains of herpes simplex virus types 1 and 2, varicella-zoster virus, and adenovirus type 27, as well as by staining CMV-infected monolayers with the conjugate alone.
Clinical specimens. Clinical specimens which were positive for CMV by TC-CPE and stored in 35% sorbitol at -70°C for up to 2 years, as well as fresh clinical specimens submitted for CMV isolation, were tested by the IPA procedure at 48 h postinfection and by TC-CPE within a 14-day incubation period. Urine, semen, respiratory secretions, and autopsy or biopsy tissue specimens were included in this study. The IPA stain was always read blindly at 48 h before the results of the TC-CPE method were known.
RESULTS
The optimal working dilution of the anti-CMV early nuclear antigen monoclonal antibody was found to be 1:25 for product 9121 and 1:5 for product 9221. The peroxidase-conjugated goat anti-mouse IgG was used at a working dilution of 1:64 to 1:128. The IPA staining procedure performed at 48 h after inoculation of duplicate monolayers with serial 10-fold dilutions of a laboratory stock of the AD-169 strain was found to be comparable in sensitivity to TC-CPE within 14 days of infection. The IPA procedure at 48 h postinfection detected CMV early nuclear antigen at up to the 10-4 dilution of the AD-169 strain. The TC-CPE procedure was also positive at up to the 10-2 dilution on day 2, but CMV CPE was not observed at the 10-3 and 10-4 dilutions until days 8 and 9 postinfection, respectively.
The specificity of the IPA stain was confirmed by the absence of staining in MRC-5 cell monolayers infected with laboratory strains of herpes simplex virus types 1 and 2, varicella-zoster virus, and adenovirus type 27, as well as in CMV-infected monolayers stained with conjugate alone. Minimal endogenous peroxidase activity resulting in a slight brownish tint to the monolayer was occasionally observed in uninoculated MRC-5 cell monolayers. This faint background stain was easily distinguished from the dark intranuclear stain specific for CMV early nuclear antigen (Fig. 1) .
Of 26 specimens obtained from 18 patients and previously found to be positive for CMV virus isolation and stored at -70°C for up to 2 years, 15 14:
on November 6, 2017 by guest http://jcm.asm.org/ upon subculture, and three remained negative. The failure to, recover CMV in tissue culture may have been due to sampling differences, since these three specimens exhibited typical nuclear staining in only one or two cells at 48 h. Of 164 fresh clinical specimens obtained from 129 patients and submitted for CMV isolation, 22 specimens from 14 patients were found to be positive for CMV by either IPA staining at 48 h or TC-CPE within 14 days ( Table 2 ). The remaining 142 specimens were negative for CMV by both procedures. Of the 22 CMV-positive specimens, 18 were positive by both methods, 2 were negative by IPA staining at 48 h but positive by TC-CPE within 14 days, and 2 were positive by IPA staining at 48 h but negative by TC-CPE within 14 days. The mean time to appearance of CPE for the 20 specimens positive by TC-CPE was 7.4 days. Of the two IPA-positive, TC-CPE-negative specimens, one was tissue culture positive on subculture and one was overgrown by herpes simplex virus type 2 before CMV CPE could develop.
Thus, the IPA stain at 48 h was positive for 28 of 30 stored or fresh clinical specimens positive for CMV by TC-CPE within 14 days (sensitivity, 93%) and was negative for 153 of 160 specimens negative for CMV isolation (specificity, 96%). The mean time to appearance of CPE for the 30 specimens positive by TC-CPE within 14 days was 6.7 days. No significant differences in sensitivity or time to appearance of CPE were observed between filtered and unfiltered samples tested in parallel by TC-CPE within 14 days. (14) + (14) _d + (12) + (4) + (2) + (14) + (6) + (13) + (11) + (14) + ( 
DISCUSSION
The results of this study demonstrate that the use of a monoclonal antibody to a CMV early nuclear antigen in an IPA stain performed 48 h after inoculation of MRC-5 cell monolayers provides diagnostic virology laboratories with a rapid and reliable method for the detection of CMV in clinical specimens.
Earlier studies with hyperimmune polyclonal antibody to CMV showed that CMV could be detected by immunofluorescence in cell culture as early as 24 h after inoculation with clinical specimens (1, 16) . Monoclonal antibodies to CMV have been produced or used for rapid diagnosis by several other groups (3-5, 8, 10, 13, 17) . These monoclonal antibodies have been used (i) to detect CMV in experimentally infected cell cultures as early as 2 to 3 h postinfection (5, 8) , (ii) for the rapid detection of CMV in lung (5, 17) and liver (13) biopsy tissue, or (iii) for the specific identification of clinical isolates of CMV after the development of CPE (3, 18) .
This study, as well as one previous report (4) , describes the use of a monoclonal antibody to CMV for the rapid detection of CMV in tissue culture monolayers inoculated with clinical specimens. However, the previous study reported that without prior low-speed centrifugation of urine specimens onto MRC-5 cell monolayers, only 37.5% of tissue culture-positive specimens were identified at 36 h postinfection by immunoperoxidase or immunofluorescence staining procedures (4). We 
